Turkish Abstract Abstract Article PDF Similar Articles Mail to Author

İstanbul Tıp Fakültesi Göz Hastalıkları A.D., İstanbul, Prof. Dr. Bevacizumab is a humanized,monoclonal antibody which inhibits all isoforms of vascular endothelial growth factor.Periodic intravitreal bevacizumab injections for treatment of choroidal neovasculararization secondary to age-related macular degeneration seems to be very promising regarding visual and anatomic results.However bevacizumab is approved by FDA for colorectal cancers and its use for ocular diseases are off-label. Keywords : Neovascular AMD, bevacizumab